Monitoring pharmacokinetics of anticancer drugs: non-invasive investigation using magnetic resonance spectroscopy
- 25 February 2000
- journal article
- review article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 41 (1), 75-89
- https://doi.org/10.1016/s0169-409x(99)00057-5
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Monitoring Local Disposition Kinetics of Carboplatinin Vivoafter Subcutaneous Injection in Rats by Means of195Pt NMRJournal of Magnetic Resonance, 1998
- Pharmacokinetics using fluorine NMR in vivoProgress in Nuclear Magnetic Resonance Spectroscopy, 1998
- In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomasBritish Journal of Cancer, 1997
- Proton NMR Observation of the Antineoplastic Agent IproplatinIn Vivo by Selective Multiple Quantum Coherence Transfer (Sel-MQC)Magnetic Resonance in Medicine, 1995
- In Vivo Selective Measurement of {1−13C}‐Glucose Metabolism in Tumors by Heteronuclear Cross PolarizationMagnetic Resonance in Medicine, 1995
- Association of intratumoral pharmacokinetics of fluorouracil with clinical responseThe Lancet, 1994
- Studies of human tumors by MRS: A reviewNMR in Biomedicine, 1992
- Monitoring therapeutic response to tamoxifen in NMU-induced rat mammary tumours by 31P MRSBritish Journal of Cancer, 1991
- A method for directin vivo measurement of drug concentrations from a single2H NMR spectrumMagnetic Resonance in Medicine, 1989
- 5-Flourouracil metabolism monitored in vivo by 19F NMRBritish Journal of Cancer, 1984